Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various clinics and treatment centers, and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $5.68 | N/A |
Market Cap | $108.02M | N/A |
Shares Outstanding | 19.01M | N/A |
Employees | 88.00 | N/A |